Computer-assisted imaging to assess brain structure in healthy and diseased brains

Lancet Neurology

Volumn 2, Issue 2, 2003, Pages 79-88

  Ashburner, John ^a   Csernansky, John G ^b   Davatzikos, Christos ^c   Fox, Nick C ^a   Frisoni, Giovanni B ^d   Thompson, Paul M ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ALGORITHM; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN ATROPHY; BRAIN FUNCTION; BRAIN MAPPING; CEPHALOMETRY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; GENOTYPE; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; IMAGE ENHANCEMENT; MINI MENTAL STATE EXAMINATION; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SEX RATIO; TEMPORAL LOBE EPILEPSY; BRAIN; BRAIN CORTEX; BRAIN DISEASE; COMPUTER ASSISTED DIAGNOSIS; DEGENERATIVE DISEASE; DISEASE COURSE; HISTOLOGY; PATHOLOGY;

ALGORITHMS; BRAIN; BRAIN DISEASES; BRAIN MAPPING; CEREBRAL CORTEX; DISEASE PROGRESSION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; NEURODEGENERATIVE DISEASES;

EID: 0042512332     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00304-1     Document Type: Review

References (74)

1. Scheltens P., Fox N., Barkhof F., De Carli C. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol. 1:2002;13-21.
2. Warmuth-Metz M., Naumann M., Csoti I., Solymosi L. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol. 58:2001;1076-1079.
3. Bhattacharya K., Saadia D., Eisenkraft B., et al. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol. 59:2002;835-842.
4. Paty D.W., Li D.K. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis, II: MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology. 43:1993;662-667.
5. Du A.T., Schuff N., Amend D., et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 71:2001;441-447.
6. Jack C.R. Jr, Petersen R.C., Xu Y.C., et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 52:1999;1397-1403.
7. Convit A., de Asis J., de Leon M.J., Tarshish C.Y., De Santi S., Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging. 21:2000;19-26.
8. Coffey C.E., Wilkinson W.E., Parashos I.A., et al. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology. 42:1992;527-536.
9. Cohen R.M., Small C., Lalonde F., Friz J., Sunderland T. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology. 57:2001;2223-2228.
10. Tohgi H., Takahashi S., Kato E., et al. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci Lett. 236:1997;21-24.
11. Jack C.R. Jr, Petersen R.C., O'Brien P.C., Tangalos E.G. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology. 42:1992;183-188.
12. Frisoni G.B., Laakso M.P., Beltramello A., et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology. 52:1999;91-100.
13. Boccardi M., Laakso M.P., Bresciani L., et al. The MRI pattern of frontal and temporal brain atrophy in frontotemporal dementia. Neurobiol Aging. 24:2003;95-103.
14. Fox N.C., Freeborough P.A. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J Magn Reson Imaging. 7:1997;1069-1075.
15. Grenander U., Miller M.I. Computational anatomy: an emerging discipline. Q Appl Math. 4:1998;617-694.
16. Ashburner J., Friston K.J. Voxel-based morphometry: the methods. Neuroimage. 14:2000;805-821.
17. Davatzikos C., Genc A., Xu D., Resnick S.M. Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy. Neuroimage. 14:2001;1361-1369.
18. Thompson P.M., Mega M.S., Toga A.W. Disease-specific brain atlases. Toga A.W., Mazziotta J.C. Brain mapping: the disorders. 2000;131-177 Academic Press, London.
19. Csernansky J.G., Joshi S., Wang L., et al. Hippocampal morphometry in schizophrenia via high dimensional brain mapping. Proc Natl Acad Sci USA. 95:1998;11406-11411.
20. Freeborough P.A., Fox N.C., Kitney R.I. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed. 53:1997;15-25.
21. Freeborough P.A., Fox N.C. Modeling brain deformations in Alzheimer's disease by fluid registration of serial 3D MR images. J Comput Assist Tomogr. 22:1998;838-843.
22. Smith SM, Zhang Y, Jenkinson M, et al. Brain atrophy analysis using single- and multiple-time-point data: FMRIB technical report TR01SMS1. http://www.fmrib.ox.ac.uk/analysis/research/siena/siena2/siena2.html (accessed Nov 18, 2002).
23. Stevenson V.L., Smith S.M., Matthews P.M., Miller D.H., Thompson A.J. Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy. J Neurol. 249:2002;171-177.
24. Ashburner J., Friston K.J. Why voxel-based morphometry should be used. Neuroimage. 14:2001;1238-1243.
25. Collins D., Holmes C., Peters T., Evans A. Automatic 3D model-based neuroanatomical segmentation. Hum Brain Mapp. 3:1995;190-208.
26. Zijdenbos AP, Evans AC, Riahi F, Sled J, Chui J, Kollokian V. Automatic quantification of multiple sclerosis lesion volume using stereotaxic space. Proceedings of the 4th International Conference on Visualization in Biomedical Computing, Hamburg, September 1996: 439-48.
27. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA. 97:2000;11050-11055.
28. Shen D, Davatzikos C. HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans Med Imaging (in press).
29. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 14:2001;21-36.
30. Friston K.J., Holmes A.P., Worsley K.J., Poline J.B., Frith C.D., Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp. 2:1995;189-210.
31. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp. 15:2002;1-25.
32. Thompson P.M., Toga A.W. A surface-based technique for warping 3-dimensional images of the brain. IEEE Trans Med Imaging. 15:1996;1-16.
33. Thompson P.M., Cannon T.D., Narr K.L., et al. Genetic influences on brain structure. Nat Neurosci. 4:2001;1253-1258.
34. Davatzikos C. Spatial normalization of 3D brain images using deformable models. J Comput Assist Tomogr. 20:1996;656-665.
35. Fischl B., Sereno M.I., Tootell R.B.H., Dale A.M. High-resolution inter-subject averaging and a coordinate system for the cortical surface. Hum Brain Mapp. 8:1999;272-284.
36. Thompson PM, Hayashi KM, de Zubicaray G, et al. Detecting dynamic and genetic effects on brain structure using high-dimensional cortical pattern matching. Proceedings of the International Symposium on Biomedical Imaging, Washington, DC, 2002 July 7-10.
37. Grenander U. General pattern theory. 1993;Oxford University Press, London.
38. Miller M.I., Christensen G.E., Amit Y., Grenander U. Mathematical textbook of deformable neuroanatomies. Proc Natl Acad Sci USA. 90:1993;11944-11948.
39. Csernansky J.G., Wang L., Joshi S., et al. Early DAT is distinguished from aging by high dimensional mapping of the hippocampus. Neurology. 55:2000;1636-1643.
40. Miller M.I., Banerjee A., Christensen G., et al. Statistical methods in computational anatomy. Stat Methods Med Res. 6:1997;267-299.
41. Wang L., Joshi S.C., Miller M.I., Grenander U., Csernansky J.G. Statistical analysis of hippocampal asymmetry. Neuroimage. 14:2001;531-545.
42. Haller J.W., Banerjee A., Christensen G.E., et al. Three-dimensional hippocampal morphometry by high dimensional transformation of a neuroanatomical atlas. Radiology. 202:1997;504-510.
43. Christensen G.E., Rabbitt R.D., Miller M.I. Deformable templates using large deformation kinematics. IEEE Trans Image Proc. 5:1996;1435-1447.
44. Walters R.J., Fox N.C., Crum W.R., Taube D., Thomas D.J. Haemodialysis and cerebral oedema. Nephron. 87:2001;143-147.
45. Smith S.M., De Stefano N., Jenkinson M., Matthews P.M. Normalised accurate measurement of longitudinal brain change. J Comput Assist Tomogr. 25:2001;466-475.
46. Resnick S.M., Goldszal A.F., Davatzikos C., et al. One-year age changes in MRI brain volumes in older adults. Cereb Cortex. 10:2000;464-472.
47. Davatzikos C., Resnick S.M. Sex differences in anatomic measures of interhemispheric connectivity: correlations with cognition in women but not in men. Cereb Cortex. 8:1998;635-640.
48. DeLacoste-Utamsing C., Holloway R.L. Sexual dimorphism in the human corpus callosum. Science. 216:1982;1431-1432.
49. Good C.D., Scahill R.I., Fox N.C., et al. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage. 17:2002;29-46.
50. Thompson P.M., Mega M.S., Woods R.P., et al. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex. 11:2001;1-16.
51. Mega M.S., Chen S., Thompson P.M., et al. Mapping pathology to metabolism: coregistration of stained whole brain sections to PET in Alzheimer's disease. Neuroimage. 5:1997;147-153.
52. Mega M.S., Chu T., Mazziotta J.C., et al. Mapping biochemistry to metabolism: FDG-PET and amyloid burden in Alzheimer's disease. Neuroreport. 10:1999;2911-2917.
53. Baron J.C., Chetelat G., Desgranges B., et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage. 14:2001;298-309.
54. Frisoni G.B., Testa C., Zorzan A., et al. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry. 73:2002;657-664.
55. Rombouts S.A., Barkhof F., Witter M.P., Scheltens P. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett. 285:2000;231-233.
56. Rosen H.J., Gorno-Tempini M.L., Goldman W.P., et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology. 58:2002;198-208.
57. Rosas H.D., Liu A.K., Hersch S., et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology. 58:2002;695-701.
58. Kassubek J., Juengling F.D., Hellwig B., Spreer J., Lucking C.H. Thalamic gray matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci Lett. 323:2002;29-32.
59. Keller S.S., Mackay C.E., Barrick T.R., Wieshmann U.C., Howard M.A., Roberts N. Voxel-based morphometric comparison of hippocampal and extrahippocampal abnormalities in patients with left and right hippocampal atrophy. Neuroimage. 16:2002;23-31.
60. Hulshoff Pol H.E., Schnack H.G., Mandl R.C., et al. Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry. 58:2001;1118-11125.
61. Franklin T.R., Acton P.D., Maldjian J.A., et al. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry. 51:2002;134-142.
62. Thompson P.M., Vidal C.N., Giedd J.N., et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA. 98:2001;11650-11655.
63. Csernansky J.G., Wang L., Jones D., et al. Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. Am J Psychiatry. 159:2002;1-7.
64. O'Neill J., Cardenas V.A., Meyerhoff D.J. Separate and interactive effects of cocaine and alcohol dependence on brain structures and metabolites: quantitative MRI and proton MR spectroscopic imaging. Addict Biol. 6:2001;347-361.
65. Fox N.C., Cousens S., Scahill R., Harvey R.J., Rossor M.N. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol. 57:2000;339-344.
66. Janssen JC, Scahill RI, Schott JM, et al. In vivo mapping of neurodegeneration in frontotemporal lobar degeneration. Proceedings of the 8th International Conference of Alzheimer's Disease and Related Disorders, Stockholm, Sweden, 2002 July 20-25: S479.
67. Chan D., Fox N.C., Jenkins R., Scahill R.I., Crum W.R., Rossor M.N. Rates of global and regional cerebral atrophy in AD and frontotemporal dementia. Neurology. 57:2001;1756-1763.
68. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
69. Fox N.C., Crum W.R., Scahill R.I., Stevens J.M., Janssen J.C., Rossor M.N. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet. 358:2001;201-205.
70. Woermann F.G., Free S.L., Koepp M.J., Ashburner J., Duncan J.S. Voxel-by-voxel comparison of automatically segmented cerebral gray matter: A rater-independent comparison of structural MRI in patients with epilepsy. Neuroimage. 10:1999;373-384.
71. Siegle G.J., Steinhauer S.R., Thase M.E., Stenger V.A., Carter C.S. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry. 51:2002;693-707.
72. Wagner A.D. Early detection of Alzheimer's disease: an fMRI marker for people at risk? Nat Neurosci. 3:2000;973-974.
73. Capizzano A.A., Schuff N., Amend D.L., et al. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy. AJNR Am J Neuroradiol. 21:2000;621-630.
74. Hsu Y.Y., Du A.T., Schuff N., Weiner M.W. Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol. 14:2001;145-166.